TURNING NOVEL DISCOVERIES INTO
INNOVATIVE HEALTH CARE SOLUTIONS.

KANE BIOTECH INC. is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. They develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the United States health care system $20 billion per year.

CORPORATE »
About Kane |
Corporate Strategy |
Management Team |
Board of Directors |
Scientific Advisory Council |
Careers

Scientific Advisory Council

Dr. Tony Romeo

Dr. Tony Romeo, Professor, Department of Microbiology and Cell Science, University of Florida is a world-renowned expert in biofilm microbiology and global regulator gene technology. Dr. Romeo's has over one hundred publications in refereed scientific journals, as well as several patents.

Dr. Romeo holds a PhD and M.Sc. from the University of Florida.

Dr. Dennis Cvitkovitch

Dr. Cvitkovitch is Professor, Faculty of Dentistry, University of Toronto, where he has been since 1998. His research focus uses a variety of biochemical, molecular biological and in silico technologies to understand the mechanisms of cell-to-cell signaling and its role in biofilm formation and genetic exchange.

Dr. Cvitkovitch has a Ph.D. in Oral Biology from the University of Manitoba and currently holds a prestigious Canada Research Chair. Dr. Cvitkovitech is a Professor in, Oral Microbiology and Institute of Biomechanics and Biomedical Engineering (IBBME) at the University of Toronto. In addition he is also the Associate Dean of Research and Director of Dental Research Institute, Faculty of Dentistry at the University of Toronto.

Dr. Jeffrey B. Kaplan

Dr. Kaplan is an Associate Professor in the Department of Oral Biology at the University of Medicine and Dentistry of New Jersey and the discoverer of the antibiofilm enzyme DispersinB®. He received a Bachelor of Science degree in Biology from the University of Illinois at Chicago in 1980 and a Ph.D. in Molecular Biology from the same institution in 1985. He received postdoctoral training in the Department of Microbiology at the Albert Einstein College of Medicine, Bronx, N.Y., and in the Department of Microbiology at Columbia University, College of Physicians and Surgeons, New York, N.Y. Dr. Kaplan worked for 10 years in the Oncology Department at Wyeth Pharmaceuticlas, Pearl River, N.Y., before joining the Department of Oral Biology at New Jersey Dental School in 1999.

Dr. Kaplan's research is supported by prestigious institutions such as the National Institute of Allergies and Infectious Diseases, the National Institute of Dental and Craniofacial Research, the University of Medicine and Dentistry of New Jersey Foundation and Genentech, Inc.